Identification of probable early-onset biomarkers for tuberculosis disease progression

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sutherland, Jayne S ^a   Hill, Philip C ^a,c   Adetifa, Ifedayo M ^a   de Jong, Bouke C ^a,d   Donkor, Simon ^a   Joosten, Simone A ^b   Opmeer, Lizet ^b   Haks, Marielle C ^b   Ottenhoff, Tom H M ^b   Adegbola, Richard A ^a,e   Ota, Martin O C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CCR7; CYTOKINE; INTERLEUKIN 18; PROTEIN BCL 2; RNA;

ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTACT EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; GAMBIA; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNITY; IMMUNOPHENOTYPING; INFECTION RISK; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NATURAL KILLER CELL; ONSET AGE; PATIENT IDENTIFICATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; RNA ANALYSIS; TUBERCULOSIS; ADULT; BLOOD; CELL CULTURE; FEMALE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL;

ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA; TUBERCULOSIS; YOUNG ADULT;

EID: 80053115808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025230     Document Type: Article

References (29)

1. Stop TB partnership: The global plan to Stop TB 2011-2015. Available at: http://www.stoptb.org/assets/documents/global/plan/TB_GlobalPlanToStopTB2011-2015.pdf Accessed 18th October, 2010.
2. Doherty M, Wallis RS, Zumla A, (2009) WHO-Tropical Disease Research/European Commission joint expert consultation group. Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med 15: 181-187.
3. Kaufmann SH, Parida SK, (2008) Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 4: 2 19-228.
4. Parida SK, Kaufmann SHE, (2009) The quest for biomarkers in tuberculosis. Drug Dis Today 15: 148-157.
5. Wallis RS, Doherty TM, Onyebujah P, Vahedi M, Laang H, et al. (2009) Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect Dis 9: 162-172.
6. Sutherland JS, Jeffries DJ, Donkor S, Walther B, Hill PC, et al. (2009) High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis(Edinb) 89: 398-404.
7. Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
8. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2010) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes and Immunity 12: 15-22.
9. Hill PC, Ota MO, (2010) Tuberculosis case-contact research in endemic tropical settings: design, conduct and relevance to other infectious diseases. Lancet Inf Dis 10: 723-732.
10. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, de Jong BC, et al. (2008) Incidence of tuberculosis and the predictive value of ELISPOT and mantoux tests in Gambian case contacts. PLoS One 3: e1379.
11. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A, (2011) Negative and positive predictive value of a whole-blood IGRA for developing active TB - an update. Am J Respir Crit Care Med 183: 88-95.
12. Lienhardt C, Fielding K, Hane AA, Niang A, Ndao CT, et al. (2010) Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One 5: e10508.
13. Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, et al. (2003) Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 31: e153.
14. White SJ, Vink GR, Kriek M, Wuyts W, Schouten J, et al. (2004) Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat 24: 86-92.
15. Joosten SA, Goeman JJ, Sutherland JS, Opmeer L, de Boer KG, et al. (2011) Identification of biomarkers for tuberculosis disease using a novel dual-colour RT-MLPA assay. Genes and Immunity In Press.
16. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med (Berl) 85: 613-621.
17. Pashine A, Valiante NM, Ulmer JB, (2005) Targeting the innate immune response with improved vaccine adjuvants. Nat Med 11: S63-S68.
18. Schultz H, Weiss JP, (2007) The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease. Clin Chim Acta 384: 12-23 Review.
19. Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondanèche MC, Tuerlinckx D, et al. (1997) Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 100: 2658-2664.
20. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MO, (2009) Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 39: 723-729.
21. Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, et al. (2000) Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med 161: 1786-1789.
22. Sada-Ovalle I, Chiba A, Gonzales A, Brenner MB, Behar SM, (2008) Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Path 4: e1000239.
23. Godfrey DI, Kronenberg M, (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114: 1379-1388.
24. Nunn P, Williams B, Floyd K, (2005) Tuberculosis control in the era of HIV. Nature Rev Imm 5: 819-826.
25. Rios-Barrerra VA, Campos-Pena V, Aguilar-Leon D, Lascurain LR, Meraz-Ríos MA, et al. (2006) Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence. Eur J Immunol 36: 345-353.
26. Stenger S, (2005) Immunological control of tuberculosis: role for tumour necrosis factor and more. Ann Rheum Dis 64: iv24-iv28.
27. Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, et al. (2010) Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. Eur J Immunol 40: 291-301.
28. Hoogerwerf J, van Zoelen MA, Wiersinga WJ, van 't Veer C, de Vos AF, et al. (2010) Gene expression profiling of apoptosis regulators in patients with sepsis. J Innate Immun 2: 461-468.
29. Kaufmann SHE, (2011) Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis 11 (8): 633-640.